Lan Dai, Ph.D.
Affiliations: | 2011 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Proteomics and Cancer ResearchGoogle:
"Lan Dai"Mean distance: 9.14 | S | N | B | C | P |
Parents
Sign in to add mentor| David M. Lubman | grad student | 2011 | University of Michigan | |
| (The application of mass spectrometry-based label-free quantitative proteomic strategies in cancer stem cell research.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dai L, Wang C, Wang W, et al. (2022) Activation of SphK2 contributes to adipocyte-induced EOC cell proliferation. Open Medicine (Warsaw, Poland). 17: 229-238 |
| Song K, Dai L, Long X, et al. (2020) Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase. Scientific Reports. 10: 13834 |
| Song K, Dai L, Long X, et al. (2019) Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo. Oncotargets and Therapy. 12: 4437-4449 |
| Dai L, Zhuang L, Zhang B, et al. (2015) DAG/PKCδ and IP3/Ca(2+)/CaMK IIβ Operate in Parallel to Each Other in PLCγ1-Driven Cell Proliferation and Migration of Human Gastric Adenocarcinoma Cells, through Akt/mTOR/S6 Pathway. International Journal of Molecular Sciences. 16: 28510-28522 |
| Ding Q, Chen Y, Zhang Q, et al. (2015) 8‑bromo‑7‑methoxychrysin induces apoptosis by regulating Akt/FOXO3a pathway in cisplatin‑sensitive and resistant ovarian cancer cells. Molecular Medicine Reports |
| Liu C, Zeng Y, Dai LH, et al. (2015) Mogrol represents a novel leukemia therapeutic, via ERK and STAT3 inhibition. American Journal of Cancer Research. 5: 1308-18 |
| Zhang N, Dai L, Qi Y, et al. (2013) Combination of FTY720 with cisplatin exhibits antagonistic effects in ovarian cancer cells: role of autophagy. International Journal of Oncology. 42: 2053-9 |
| Dai L, He J, Liu Y, et al. (2011) Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor. Proteomics. 11: 4529-40 |
| Dai L, Liu Y, He J, et al. (2011) Differential profiling studies of N-linked glycoproteins in glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor. Proteomics. 11: 4021-8 |
| Liu YH, Wang ZY, Dai L, et al. (2010) [Influence of arsenic trioxide and daunorubicin on the expression of annexin II and fibrinolytic activity in NB4 cells.] Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi. 31: 813-816 |